http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113508175-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a84c8d19902fd5dd08dce4bf2e657d21 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16043 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1138 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
| filingDate | 2019-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7924e32e8936152129e258239b4612d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf9a4345c33de18e6d01b7bd86099e0d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_430fb965e5a8ca7ce22a2781a0035773 |
| publicationDate | 2021-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113508175-A |
| titleOfInvention | Compositions and methods for treating cancer |
| abstract | A double-stranded RNA interference (RNAi) agent comprising at least one of: (i) a first double-stranded ribonucleic acid (dsRNA) for inhibiting CD320 gene expression, wherein the first dsRNA comprises a sense strand forming a duplex and the antisense strand, (ii) a second dsRNA for inhibiting LRP2 gene expression, wherein the second dsRNA comprises a duplex-forming sense and antisense strand, or (iii) a mixture of (i) and (ii), and wherein the sense strand of the first dsRNA is at least substantially complementary to the antisense strand of the first dsRNA, and the sense strand of the second dsRNA is at least substantially complementary to the antisense strand of the second dsRNA, and the RNAi agent acts as a treatment for a subject in need of treatment. Use of a pharmaceutical composition for cancer in a subject. |
| priorityDate | 2018-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 993.